PBDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Protalix Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 2 EUR -0.99%

Market Cap: €146.6m

	Protalix Biotherapeutics Inc F:PBDA	US
	Toyota Boshoku Corp F:TY7	JP
T	Tyson Foods Inc DUS:TF7A	US

Profitability Summary

Protalix Biotherapeutics Inc's profitability score is 28/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

49%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

72% > 49%

Negative Operating Margin

-10%

Low 3Y Average Operating Margin

Declining Operating Margin

18% > -10%

Negative Net Margin

-13%

Low 3Y Average Net Margin

Declining Net Margin

13% > -13%

Negative Free Cash Flow Margin

-26%

Negative 3Y Average Free Cash Flow Margin

-5%

Declining Free Cash Flow Margin

-16% > -26%

Negative ROE

-14%

Positive 3Y Average ROE

View All

Hide

Collapse

28 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.